Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Baldrick

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Regulatory Toxicology and Pharmacology : RTP|February 8, 2022
Successful regulatory agency interaction - A nonclinical regulatory strategist's perspectivePaul Baldrick
Journal of Applied Toxicology : JAT|August 25, 2020
Nonclinical safety testing of imaging agents, contrast agents and radiopharmaceuticalsPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|February 28, 2026
Oncology Drugs: Target Organ Findings Seen In Animal Toxicity TestingPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|March 31, 2010
Juvenile animal testing in drug development--is it useful?Paul Baldrick
Toxicologic Pathology|May 21, 2005
Carcinogenicity evaluation: comparison of tumor data from dual control groups in the Sprague-Dawley ratPaul Baldrick
Journal of Applied Toxicology : JAT|March 13, 2016
Dose site reactions and related findings after vaccine administration in safety studiesPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|July 29, 2017
Getting a molecule into the clinic: Nonclinical testing and starting dose considerationsPaul Baldrick
International Journal of Toxicology|December 26, 2022
Nonclinical Testing Evaluation of Liposomes as Drug Delivery SystemsPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|March 16, 2025
Current nonclinical testing paradigm to allow clinical entry for pharmaceutical drug candidatesPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|October 13, 2010
Safety evaluation of biological drugs: what are toxicology studies in primates telling us?Paul Baldrick
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Regulatory Toxicology and Pharmacology : RTP|February 8, 2022
Successful regulatory agency interaction - A nonclinical regulatory strategist's perspectivePaul Baldrick
Journal of Applied Toxicology : JAT|August 25, 2020
Nonclinical safety testing of imaging agents, contrast agents and radiopharmaceuticalsPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|February 28, 2026
Oncology Drugs: Target Organ Findings Seen In Animal Toxicity TestingPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|March 31, 2010
Juvenile animal testing in drug development--is it useful?Paul Baldrick
Toxicologic Pathology|May 21, 2005
Carcinogenicity evaluation: comparison of tumor data from dual control groups in the Sprague-Dawley ratPaul Baldrick
Journal of Applied Toxicology : JAT|March 13, 2016
Dose site reactions and related findings after vaccine administration in safety studiesPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|July 29, 2017
Getting a molecule into the clinic: Nonclinical testing and starting dose considerationsPaul Baldrick
International Journal of Toxicology|December 26, 2022
Nonclinical Testing Evaluation of Liposomes as Drug Delivery SystemsPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|March 16, 2025
Current nonclinical testing paradigm to allow clinical entry for pharmaceutical drug candidatesPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|October 13, 2010
Safety evaluation of biological drugs: what are toxicology studies in primates telling us?Paul Baldrick
Pageof 6